Well, I'd like to hear from you to tell me how good.
I've spent the past few weeks reflecting on my own trading transformation in 2025—the wins, the lessons, the shifts in confidence and approach. But I'm...
Today’s most notable transaction comes via a Form 4 filing by EcoR1 Capital LLC, a biotech-focused hedge fund known for its expertise in high-growth life sciences investments.
Below is the 12th ASC Mastermind Course. In this video, I dive answer a question that every new trader/investor wants to know: how do I find the next $100 Billion stock?
Here is a list of trade ideas organized by date, ticker symbol and directional bias. Please make sure you have clicked on the link and read the details surrounding the trade before acting upon any of them. Also, make sure you have checked with your...
Many have turned to the new "wonder drugs" (GLP-1 receptor agonists) from Eli Lilly and Novo Nordisk. Unfortunately, these drugs aren't the cure for everyone.
Every year we see an extended trend, going into late December, that extends just a bit too much, and then completely unwinds once the new year begins and the big portfolio...
